• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions

    12/2/24 8:45:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $SYRA alert in real time by email

    - Now Available for Download on the App Store and Google Play Store.

    Syra Health - A catalyst for improving health outcomes. (PRNewsfoto/Syra Health)

    CARMEL, Ind., Dec. 2, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that its flagship mental health app, Syrenity, is now available for direct download by adults 18 years and older. Syrenity leverages a science-driven approach to address prevalent mental health challenges such as stress, anxiety, and depression, positioning the Company to capture growth opportunities in the expanding digital mental health market while advancing its mission to deliver impactful, scalable solutions for improved health outcomes.

    "At Syra Health, we are committed to breaking down barriers by making mental health care accessible to everyone," said Dr. Deepika Vuppalanchi, CEO of Syra Health. "With Syrenity, we have developed an app that combines cutting-edge technology with clinically validated methods and real-time data insights to provide personalized solutions that empower individuals to manage their mental health. This launch marks a significant milestone in our mission to provide effective and scalable mental health support to those who need it most."

    The global mental health app market is projected to grow significantly, from $6 billion in 2023 to over $30 billion by 2033. This growth is driven by increased awareness of mental health concerns and a rising demand for accessible solutions. Syrenity is strategically positioned to meet this demand by offering clinically validated mental health interventions directly to consumers.

    Leveraging artificial intelligence, Syrenity provides a highly personalized user experience. "A key feature of Syrenity is its 24/7 AI-powered companion, Echo," said Dr. Srikant Devaraj, VP of Innovation and Growth at Syra Health. "Echo alleviates social isolation by prompting AI-backed journal entries, offering empathy and support, reminding users of daily goals, and continuously adapting to individual needs based on real-time progress tracking."

    Built uniquely on the latest cognitive behavioral therapy (CBT), mindfulness-based stress reduction (MBSR), and neuroscience research, Syrenity's development is guided by a team of clinical psychologists, neuroscientists, and data scientists. Syra Health's partnerships with academic institutions further validate the app's efficacy through ongoing evaluation.

    Syrenity provides an intuitive and personalized mental health experience, starting with a comprehensive baseline assessment. Sophisticated algorithms analyze user responses to generate precise risk scores, enabling tailored interventions that help prevent conditions from escalating.

    By combining education with practical exercises, Syrenity acts as both a mirror, reflecting users' progress, and a dynamic tool for their mental health journey. Real-time reporting enhances its functionality, offering two types of reports: one tracking mental health improvements and another providing AI-generated clinical summaries with actionable insights to guide future steps. With a strong commitment to data security, Syrenity is fully HIPAA-compliant, employing advanced encryption and strict protocols to ensure user confidentiality.

    In addition to its consumer-facing product, Syrenity is also available as a customizable business-to-business solution. The app can be tailored to meet the needs of healthcare providers, payers, life science organizations, and academic institutions, seamlessly integrating into existing systems.

    Initially launched in the United States, Syra Health plans to strategically expand Syrenity's reach to select lower-to-middle-income countries, tapping into markets with high unmet mental health needs. This expansion presents significant growth opportunities, aligning with Syra Health's mission to address global mental health challenges while diversifying its revenue streams.

    ABOUT SYRA HEALTH

    Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.

    Forward-Looking Statements 

    Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

    For Investor or Media Inquiries:

    Christine Drury

    IR/PR

    Syra Health

    463-345-5180

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-launches-syrenity-an-evidence-based-app-for-managing-common-mental-health-conditions-302319270.html

    SOURCE Syra Health

    Get the next $SYRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the latest product launched by Syra Health Corp.?

      Syra Health Corp.'s flagship mental health app, Syrenity, is now available for download on the App Store and Google Play Store for adults 18 years and older.

    • What is the projected growth of the global mental health app market?

      The global mental health app market is projected to grow from $6 billion in 2023 to over $30 billion by 2033 due to increased awareness and demand for accessible mental health solutions.

    • How does Syrenity differentiate itself in the mental health app market?

      Syrenity employs cutting-edge technology alongside clinically validated methods, including AI-driven personalized interventions and real-time data insights.

    • What are some key features of the Syrenity app?

      The app includes features such as a 24/7 AI-powered companion, Echo, which provides support through prompted journal entries and monitoring user progress.

    • What are Syra Health's plans for expanding Syrenity's availability in the future?

      Syra Health plans to expand Syrenity's reach to select lower-to-middle-income countries where there are high unmet mental health needs, thus increasing potential market opportunities.

    Recent Analyst Ratings for
    $SYRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SYRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    9/13/24 9:10:53 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    SEC Filings

    View All

    SEC Form 10-K filed by Syra Health Corp.

    10-K - Syra Health Corp (0001922335) (Filer)

    3/12/26 5:25:54 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    3/12/26 9:29:06 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    12/18/25 9:48:37 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Alexander Gregory R. was granted 110,537 units of Restricted Stock Units (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    2/3/26 4:30:22 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Alexander Gregory R.

    3 - Syra Health Corp (0001922335) (Issuer)

    1/14/26 5:05:31 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Mereddy Radhika

    3 - Syra Health Corp (0001922335) (Issuer)

    1/13/26 4:54:25 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana

    Collaboration connects AI-powered digital behavioral health platform, Syrenity, with licensed therapists to deliver seamless, affordable careCARMEL, Ind., April 2, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today a partnership with Nora Mental Health to expand access to mental and behavioral health services across Indiana through telehealth integration with Syra Health's Syrenity behavioral health solution.

    4/2/26 4:51:00 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026

    FY2025 EPS improved to ($0.08) compared to ($0.50) in FY2024YoY net loss reduced 76% to ($896K) from ($3.8M) in FY2024Population health revenue grew 157% to $5.3 million versus $2.1 million in FY2024Operating expenses declined 37% to $3.4 million compared to $5.4 million in FY2024CARMEL, Ind., March 12, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the fourth quarter and full year ended December 31, 2025.

    3/12/26 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results

    CARMEL, Ind., March 5, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for its fourth quarter and fiscal year ended December 31, 2025, on Thursday, March 12, 2026. The results will be shared in a press release before the market opens.About Syra HealthSyra Health is an integrated healthcare solutions company serving government and commercial healthca

    3/5/26 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Leadership Updates

    Live Leadership Updates

    View All

    Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

    Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind., Dec. 18, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Gregory R. Alexander as Chief Executive Officer, effective January 5, 2026. Alexander's career has been defined by consistently driving growth and excee

    12/18/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Board Begins CEO Search to Drive Growth

    CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

    5/20/25 9:00:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Financials

    Live finance-specific insights

    View All

    Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

    Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

    5/8/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Discuss First Quarter 2025 Financial Results

    Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

    5/1/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

    2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

    3/11/25 7:43:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Syra Health Corp.

    SC 13G - Syra Health Corp (0001922335) (Subject)

    2/20/24 3:01:17 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary